News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeuroVive Pharmaceutical AB First Day of Trading on NASDAQ OMX Stockholm



4/10/2013 11:27:36 AM

Lund (Sweden) – April 10, 2013, NeuroVive Pharmaceutical AB (publ), a leading mitochondrial medicine company, announces that its admission to NASDAQ OMX Stockholm will become effective and trading of the shares will start at 09.00 am (CET) today, 10th April 2013.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES